These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9389340)

  • 1. Determination of unbound warfarin enantiomers in human plasma and 7-hydroxywarfarin in human urine by chiral stationary-phase liquid chromatography with ultraviolet or fluorescence and on-line circular dichroism detection.
    Takahashi H; Kashima T; Kimura S; Muramoto N; Nakahata H; Kubo S; Shimoyama Y; Kajiwara M; Echizen H
    J Chromatogr B Biomed Sci Appl; 1997 Nov; 701(1):71-80. PubMed ID: 9389340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous determination of warfarin and 7-hydroxywarfarin enantiomers by high-performance liquid chromatography with ultraviolet detection.
    Miura M; Okuyama S; Kato S; Kagaya H; Murata A; Komatsuda A; Wakui H; Sawada K
    Ther Drug Monit; 2011 Feb; 33(1):108-14. PubMed ID: 21157402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous determination of warfarin enantiomers and its metabolite in human plasma by column-switching high-performance liquid chromatography with chiral separation.
    Uno T; Niioka T; Hayakari M; Sugawara K; Tateishi T
    Ther Drug Monit; 2007 Jun; 29(3):333-9. PubMed ID: 17529891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous measurement of S-warfarin, R-warfarin, S-7-hydroxywarfarin and R-7-hydroxywarfarin in human plasma by liquid chromatography-tandem mass spectrometry.
    Zuo Z; Wo SK; Lo CM; Zhou L; Cheng G; You JH
    J Pharm Biomed Anal; 2010 Jun; 52(2):305-10. PubMed ID: 20133101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of warfarin enantiomers and hydroxylated metabolites in human blood plasma by liquid chromatography with achiral and chiral separation.
    Locatelli I; Kmetec V; Mrhar A; Grabnar I
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Apr; 818(2):191-8. PubMed ID: 15734158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereospecific fluorescence high-performance liquid chromatographic analysis of warfarin and its metabolites in plasma and urine.
    Banfield C; Rowland M
    J Pharm Sci; 1984 Oct; 73(10):1392-6. PubMed ID: 6502487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Separation of the enantiomers of phenprocoumon and warfarin by high-performance liquid chromatography using a chiral stationary phase. Determination of the enantiomeric ratio of phenprocoumon in human plasma and urine.
    de Vries JX; Völker U
    J Chromatogr; 1989 Aug; 493(1):149-56. PubMed ID: 2778004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of warfarin enantiomers and metabolites in patients during multiple dosing with rac-warfarin.
    Chan E; McLachlan AJ; Pegg M; MacKay AD; Cole RB; Rowland M
    Br J Clin Pharmacol; 1994 Jun; 37(6):563-9. PubMed ID: 7917775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of warfarin enantiomers in Japanese patients with heart disease having different CYP2C9 and CYP2C19 genotypes.
    Takahashi H; Kashima T; Nomizo Y; Muramoto N; Shimizu T; Nasu K; Kubota T; Kimura S; Echizen H
    Clin Pharmacol Ther; 1998 May; 63(5):519-28. PubMed ID: 9630825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel multi-mode ultra performance liquid chromatography-tandem mass spectrometry assay for profiling enantiomeric hydroxywarfarins and warfarin in human plasma.
    Jones DR; Boysen G; Miller GP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 May; 879(15-16):1056-62. PubMed ID: 21470921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous determination of warfarin and 7-hydroxywarfarin in rat plasma by HPLC-FLD.
    Zayed A; Babaresh WM; Darweesh RS; El-Elimat T
    Acta Pharm; 2020 Sep; 70(3):343-357. PubMed ID: 32074068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of R- and S-hydroxywarfarin glucuronidation catalyzed by human liver microsomes and recombinant UDP-glucuronosyltransferases.
    Bratton SM; Mosher CM; Khallouki F; Finel M; Court MH; Moran JH; Radominska-Pandya A
    J Pharmacol Exp Ther; 2012 Jan; 340(1):46-55. PubMed ID: 21972237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The measurement of warfarin enantiomers in serum using coupled achiral/chiral, high-performance liquid chromatography (HPLC).
    Chu YQ; Wainer IW
    Pharm Res; 1988 Oct; 5(10):680-3. PubMed ID: 3244624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination index of the concentration and in vivo antagonism activity of racemic warfarin and its metabolites to assess individual drug responses.
    Kobayashi S; Ishii K; Yamada Y; Ryu E; Hashizume J; Nose S; Hara T; Nakashima M; Ohyama K
    J Thromb Thrombolysis; 2019 Apr; 47(3):467-472. PubMed ID: 30465164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous determination of disopyramide and its mono-N-dealkylated metabolite enantiomers in human plasma and urine by enantioselective high-performance liquid chromatography.
    Takahashi H; Tamura A; Ogata H; Masuhara K
    J Chromatogr; 1990 Aug; 529(2):347-58. PubMed ID: 2229254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of phenprocoumon, warfarin and their monohydroxylated metabolites in human plasma and urine by liquid chromatography-mass spectrometry after solid-phase extraction.
    Ufer M; Kammerer B; Kirchheiner J; Rane A; Svensson JO
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 809(2):217-26. PubMed ID: 15315768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A chiral HPLC-MS/MS method for simultaneous quantification of warfarin enantiomers and its major hydroxylation metabolites of CYP2C9 and CYP3A4 in human plasma.
    Ju W; Peng K; Yang S; Sun H; Sampson M; Wang MZ
    Austin J Anal Pharm Chem; 2014; 1(2):. PubMed ID: 26161443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of drugs in cystic fibrosis. VI. In vivo activity of cytochrome P450 isoforms involved in the metabolism of (R)-warfarin (including P450 3A4) is not enhanced in cystic fibrosis.
    Wang JP; Unadkat JD; McNamara S; O'Sullivan TA; Smith AL; Trager WF; Ramsey B
    Clin Pharmacol Ther; 1994 May; 55(5):528-34. PubMed ID: 8181197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Active Metabolite of Warfarin (3'-Hydroxywarfarin) and Correlation with INR, Warfarin and Drug Weekly Dosage in Patients under Oral Anticoagulant Therapy: A Pharmacogenetics Study.
    Gemmati D; Burini F; Talarico A; Fabbri M; Bertocco C; Vigliano M; Moratelli S; Cuneo A; Serino ML; Avato FM; Tisato V; Gaudio RM
    PLoS One; 2016; 11(9):e0162084. PubMed ID: 27606428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simplified high-performance liquid chromatographic method for direct determination of warfarin enantiomers and their protein binding in stroke patients.
    Cai WM; Hatton J; Pettigrew LC; Dempsey RJ; Chandler MH
    Ther Drug Monit; 1994 Oct; 16(5):509-12. PubMed ID: 7846751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.